Viola W. Zhu
0000-0002-9313-3253
Publication & Citation Trends
Publications
0 total
Neladalkib (NVL-655), a highly selective anaplastic lymphoma kinase (ALK) inhibitor, compared to alectinib in first-line treatment of patients with ALK-positive advanced non-small cell lung cancer: The phase 3 ALKAZAR study.
Cited by 4
Semantic Scholar
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer OA
Cited by 86
Semantic Scholar
Abstract B154: Safety and preliminary activity of the selective ALK inhibitor NVL-655 in patients with ALK fusion-positive solid tumors
Cited by 2
Semantic Scholar
Antitumor activity of sunvozertinib in NSCLC patients with EGFR Exon20 insertion mutations after platinum and anti-PD(L)1 treatment failures.
Cited by 11
Semantic Scholar
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations OA
Cited by 33
Semantic Scholar
INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance
Cited by 0
Semantic Scholar
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study OA
Cited by 10
Semantic Scholar
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations OA
Cited by 90
Semantic Scholar
Journal Pre-proof rThe Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic Driven Non-Small Cell Lung Cancer: A University California Lung Cancer Consortium Retrospective Study
Cited by 0
Semantic Scholar
Acquired Resistance to KRASG12C Inhibition in Cancer. OA
Cited by 431
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(148)
Lung Cancer Research Studies
(47)
Colorectal Cancer Treatments and Studies
(40)
Cancer Genomics and Diagnostics
(33)
Cancer therapeutics and mechanisms
(25)
Affiliations
Boston Medical Center
Institute of Contemporary Art
Harvard University
University of California, San Francisco
Chapman University